FY2025 · ended Dec 31, 2025 · Revenue $1.36M, +111.4% YoY · Filed Mar 30, 2026
Onemednet Corporation (ONMD) files with the SEC under industry code 8731, Services-Commercial Physical & Biological Research. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $1.4 million and a net loss of $2.8 million. Free cash flow was -$7.5 million. As of Jun 30, 2026 it held $358,000 in cash and investments and $132,000 in total debt.
Revenue (TTM)
$1.46M
+217.0% vs year-ago TTM
Net income (TTM)
$-8.51M
-153.8% vs year-ago TTM
Operating cash flow (TTM)
$-6.88M
+13.4% vs year-ago TTM
Free cash flow (TTM)
$-6.89M
+13.8% vs year-ago TTM
EPS (TTM)
$-0.16
-59.5% vs year-ago TTM
Dividend per share
None
Shares outstanding
52.20M
+69.7% vs prior year
Net cash
$226,000
as of Jun 30, 2026
Operating margin
-696.2%
FY 2026
Company profile
- Industry
- Services-Commercial Physical & Biological Research (SIC 8731)
- Listed as
- ONMD (Nasdaq), ONMDW (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Surrey, United Kingdom
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1849380
- Former names
- Data Knights Acquisition Corp. (until Nov 7, 2023)
Other Services-Commercial Physical & Biological Research companies
- Iqvia Holdings Inc. IQV
- Incyte Corp INCY
- Medpace Holdings, Inc. MEDP
- Charles River Laboratories International, Inc. CRL
- Icon PLC ICLR
- Absci Corp ABSI
- OmniAb, Inc. OABI
- NRC Health NRC
All 17 Services-Commercial Physical & Biological Research companies
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Dec 31, 2025 |
FY 2024 Dec 31, 2024 |
FY 2023 Dec 31, 2023 |
FY 2022 Dec 31, 2022 |
FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $1.4M | $643,000 | $1.0M | — | — |
| Operating income | -$9.7M | -$9.6M | -$6.9M | -$7.7M | -$585,405 |
| Net income | -$2.8M | -$10.1M | -$33.8M | -$30.5M | $5.1M |
| Diluted EPS | -$0.06 | -$0.36 | -$4.65 | -$7.66 | — |
| Operating cash flow | -$7.5M | -$7.0M | -$4.8M | -$4.7M | -$378,487 |
| Free cash flow | -$7.5M | -$7.0M | -$4.8M | — | — |
| Total assets | $2.2M | $3.7M | $464,000 | $1.3M | $117.9M |
| Total liabilities | $5.1M | $19.7M | $13.9M | $27.6M | $9.2M |
| Stockholders' equity | -$3.0M | -$15.9M | -$13.4M | -$26.4M | -$7.1M |
| Cash and investments | $585,000 | $172,000 | $47,000 | $271,000 | $453,151 |
| Total debt | $220,000 | $4.6M | — | — | — |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Other events
|
Oct 14, 2026 | Oct 13, 2026 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change
|
Sep 29, 2026 | Sep 26, 2026 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Sep 23, 2026 | Sep 18, 2026 |
| 10-Q | Quarterly report | Aug 14, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Other events
|
Jul 24, 2026 | Jul 24, 2026 |
| 8-K |
Current report
Material agreement
|
Jul 1, 2026 | Jul 1, 2026 |
All 289 Onemednet Corporation SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.